RSPI — Respirerx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Respirerx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.033	0.017	0.001	0.001	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.121	0.045	0.085	0.209	0.023
Other Long Term Assets
Total Assets	0.124	0.045	0.085	0.209	0.023
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	5.86	7.49	8.15	9.92	11.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	5.86	7.49	8.15	10.2	11.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-5.73	-7.44	-8.06	-10	-11.9
Total Liabilities & Shareholders' Equity	0.124	0.045	0.085	0.209	0.023
Total Common Shares Outstanding
Total Preferred Shares Outstanding